Skip to main content
. 2017 Nov 29;20(4):445–456. doi: 10.1093/neuonc/nox166

Table 3.

Key recommendations for the treatment of recurrent intracranial ependymomas in adults and children

Class of Evidence Level of Recommendation
Re-operation and/or re-irradiation should be proposed whenever possible. However, if only incomplete resection was achievable due to functional restrictions at first surgery, the same limitations will be faced at re-operation; hence, in these cases the indication for another incomplete resection should be made cautiously. III C
In patients with recurrent ependymomas who are no longer eligible for local treatments, chemotherapy might be warranted, particularly in patients with a good performance status. III C
In adults, either platinum compounds or temozolomide (based on a more favorable toxicity profile) should be considered. Options for participation in a clinical trial should be explored. IV Good Practice Point
In children, the choice of chemotherapeutic drugs depends on previous exposures. Options for participation in a clinical trial should be explored. n.a. Good Practice Point